Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 651-658, October 2008

The Cost of Medical Management in Advanced Heart Failure During the Final Two Years of Life

Received 14 March 2008; received in revised form 27 May 2008; accepted 2 June 2008. published online 21 July 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Presented at the 2006 American Heart Association Scientific Sessions, November 12 to 15, 2006, Chicago, Illinois.

 The REMATCH trial was supported, in part, by a cooperative agreement (HL-53986) funded by the National Heart Lung and Blood Institute of the National Institutes of Health, Bethesda, Maryland, and Thoratec Corporation, Pleasanton, California. Additional funding for the routine costs of clinical care associated with the trial was made available by the Center for Medicare and Medicaid Services and by the participating clinical centers. Reprint requests: Mark J. Russo, MD, MS, New York-Presbyterian Hospital/Columbia, Milstein Hospital Bldg, Room 7-435 GN, 177 Fort Washington Avenue, New York, NY 10032.

PII: S1071-9164(08)00180-2

doi:10.1016/j.cardfail.2008.06.005

Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 651-658, October 2008